Products found to contain undeclared medicines
|
| |
| The United States: Hi-Tech Pharmaceuticals issues voluntary recall on Lipodrene w／25mg Ephedra Extract Dietary Supplement due to the presence of 1,4-dimethylamylamine (DMAA) |
| |
The US Food and Drug Administration (FDA) announces that Hi-Tech Pharmaceuticals Inc. is recalling Lot # 001211197, Exp. 12/25 of Lipodrene w/25mg Ephedra Extract Dietary Supplement due to the presence of 1,4-dimethylamylamine (DMAA). The FDA has warned that DMAA is dangerous because it can narrow blood vessels and arteries and cause a corresponding rise in blood pressure or other cardiovascular problems, such as shortness of breath, arrhythmias, elevated blood pressure, tightening in the chest, and heart attack. Hi-Tech Pharmaceuticals Inc. is conducting a continuing investigation on the problem. There have been no reported illnesses to date.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hi-tech-pharmaceuticals-issues-voluntary-recall-lipodrene-w25mg-ephedra-extract-dietary-supplement
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Thursday, May 13, 2021
Issued at HKT 17:00
|
| |
